Addressing Unanswered Questions in Lung Cancer Survivorship Care—Home-Based Physical Activity After Surgery
Mené sur 116 patients ayant subi une chirurgie pour un cancer du poumon non à petites cellules sur la période 2017-2023 (âge moyen : 66,4 ans ; 58,6 % de femmes), cet essai randomisé évalue l'effet, sur la fonction physique, d'un programme comportant des exercices physiques et une auto-prise en charge postopératoire à domicile pendant 3 mois
Strides are being made across the spectrum of lung cancer care. In the United States, tobacco smoking rates are at an all-time low, early disease recognition is facilitated by screening and lung nodule programs, local treatments are better tolerated (ie, sublobar resection, stereotactic radiation, and ablative techniques), and modern systemic therapies (ie, targeted therapies and immunotherapies) are more numerous and more effective than prior treatment options. As a result of these advances, improvements in lung cancer survival and mortality are accelerating.Steady reduction in lung cancer mortality has highlighted a new set of opportunities in lung cancer care: promoting health and optimizing health-related quality of life (HR-QoL) in anticipation of long-term survival. The National Cancer Institute defines a cancer survivor “from the time of diagnosis throughout the balance of life.” Thus, cancer survivorship care aims to improve short- and long-term outcomes and encompasses care during and after cancer-directed therapy. Given that lung cancer survivors experience more frequent and severe symptoms, functional impairments, and HR-QoL impairments than survivors of other cancer types, effective survivorship care is crucial to preventing disability. Concerningly, symptoms and HR-QoL in lung cancer survivors may worsen during cancer treatment and often extend beyond treatment completion. Nugent and colleagues showed that approximately 30% of patients undergoing treatment for early-stage lung cancer have HR-QoL impairments at 1 year. HR-QoL impairments in patients with advanced stage disease are even more common. In sum, lung cancer survivorship treatment options are urgently needed to address HR-QoL and functional impairments during and after lung cancer–directed care.